| Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study RS Chinthrajah, N Purington, S Andorf, A Long, KL O'Laughlin, SC Lyu, ... The Lancet 394 (10207), 1437-1449, 2019 | 237 | 2019 |
| Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial S Andorf, N Purington, WM Block, AJ Long, D Tupa, E Brittain, AR Spergel, ... The lancet Gastroenterology & hepatology 3 (2), 85-94, 2018 | 215 | 2018 |
| Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial P Jagannathan, JR Andrews, H Bonilla, H Hedlin, KB Jacobson, ... Nature Communications 12 (1), 1967, 2021 | 126 | 2021 |
| A phase 2 randomized controlled multisite study using omalizumab-facilitated rapid desensitization to test continued vs discontinued dosing in multifood allergic individuals S Andorf, N Purington, D Kumar, A Long, KL O'Laughlin, S Sicherer, ... EClinicalMedicine 7, 27-38, 2019 | 95 | 2019 |
| Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer A Afghahi, N Purington, SS Han, M Desai, E Pierson, MB Mathur, T Seto, ... Clinical Cancer Research 24 (12), 2851-2858, 2018 | 75 | 2018 |
| Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis E Gars, N Purington, G Scott, K Chisholm, D Gratzinger, BA Martin, ... Haematologica 103 (10), 1635, 2018 | 68 | 2018 |
| Development of a tool predicting severity of allergic reaction during peanut challenge RS Chinthrajah, N Purington, S Andorf, JS Rosa, K Mukai, R Hamilton, ... Annals of Allergy, Asthma & Immunology 121 (1), 69-76. e2, 2018 | 65 | 2018 |
| Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges N Purington, RS Chinthrajah, A Long, S Sindher, S Andorf, K O'Laughlin, ... Frontiers in immunology 9, 2057, 2018 | 53 | 2018 |
| Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy BL Wright, NQ Fernandez-Becker, N Kambham, N Purington, D Tupa, ... Frontiers in immunology 9, 2624, 2018 | 51 | 2018 |
| A common polymorphism in the mechanosensitive ion channel PIEZO1 is associated with protection from severe malaria in humans CN Nguetse, N Purington, ER Ebel, B Shakya, M Tetard, PG Kremsner, ... Proceedings of the National Academy of Sciences 117 (16), 9074-9081, 2020 | 47 | 2020 |
| Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy BL Wright, NQ Fernandez-Becker, N Kambham, N Purington, S Cao, ... Clinical Gastroenterology and Hepatology 19 (6), 1151-1159. e14, 2021 | 43 | 2021 |
| Using data from food challenges to inform management of consumers with food allergy: a systematic review with individual participant data meta-analysis N Patel, DC Adelman, K Anagnostou, JL Baumert, WM Blom, ... Journal of Allergy and Clinical Immunology 147 (6), 2249-2262. e7, 2021 | 39 | 2021 |
| Favipiravir for treatment of outpatients with asymptomatic or uncomplicated coronavirus disease 2019: a double-blind, randomized, placebo-controlled, phase 2 trial M Holubar, A Subramanian, N Purington, H Hedlin, B Bunning, KS Walter, ... Clinical Infectious Diseases 75 (11), 1883-1892, 2022 | 38 | 2022 |
| Analysis of a large standardized food challenge data set to determine predictors of positive outcome across multiple allergens S Sindher, AJ Long, N Purington, M Chollet, S Slatkin, S Andorf, D Tupa, ... Frontiers in immunology 9, 2689, 2018 | 31 | 2018 |
| Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome X Jia, S Cao, AS Lee, M Manohar, SB Sindher, N Ahuja, M Artandi, ... JCI insight 7 (13), 2022 | 27 | 2022 |
| Peanut can be used as a reference allergen for hazard characterization in food allergen risk management: a rapid evidence assessment and meta-analysis PJ Turner, N Patel, BK Ballmer-Weber, JL Baumert, WM Blom, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (1), 59-70, 2022 | 27 | 2022 |
| Phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’study SB Sindher, D Kumar, S Cao, N Purington, A Long, V Sampath, ... Allergy 77 (6), 1873-1884, 2022 | 21 | 2022 |
| Genomic landscape of ductal carcinoma in situ and association with progression CY Lin, S Vennam, N Purington, E Lin, S Varma, S Han, M Desa, T Seto, ... Breast cancer research and treatment 178, 307-316, 2019 | 21 | 2019 |
| Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing K Vlessis, N Purington, N Chun, S Haraldsdottir, JM Ford JNCI cancer spectrum 4 (1), pkz095, 2020 | 18 | 2020 |
| Healthcare utilization in children across the care continuum during the COVID-19 pandemic AR Schroeder, A Dahlen, N Purington, F Alvarez, R Brooks, L Destino, ... PLoS One 17 (10), e0276461, 2022 | 16 | 2022 |
